Omeros Closes $68.3 Million Public Offering of Common Stock

15:25 EDT 21 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Omeros Corporation (NASDAQ: OMER) today announced that on August 18, 2017, as scheduled, it closed the underwritten public offering that was priced on August 14, 2017, relating to the sale of 3,000,000 shares of its common stock...

Other Sources for this Article

Cook Williams Communications, Inc.
Investor and Media Relations
Jennifer Cook Williams, 360-668-3701


More From BioPortfolio on "Omeros Closes $68.3 Million Public Offering of Common Stock"

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...